| Year |
Citation |
Score |
| 2019 |
Kim B, De La Monte S, Hovanesian V, Patra A, Chen X, Chen RH, Miller MC, Pinar MH, Lim YP, Stopa EG, Stonestreet BS. Ontogeny of inter-alpha inhibitor protein (IAIP) expression in human brain. Journal of Neuroscience Research. PMID 31797408 DOI: 10.1002/Jnr.24565 |
0.361 |
|
| 2019 |
Agca C, Klakotskaia D, Stopa EG, Schachtman TR, Agca Y. Ovariectomy Influences Cognition and Markers of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31796679 DOI: 10.3233/Jad-190935 |
0.355 |
|
| 2019 |
Chen X, Nakada S, Donahue JE, Chen RH, Tucker R, Qiu J, Lim YP, Stopa EG, Stonestreet BS. Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats. Experimental Neurology. PMID 30914159 DOI: 10.1016/J.Expneurol.2019.03.013 |
0.316 |
|
| 2018 |
Kant S, Stopa EG, Johanson CE, Baird A, Silverberg GD. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease. Fluids and Barriers of the Cns. 15: 34. PMID 30541599 DOI: 10.1186/S12987-018-0120-7 |
0.377 |
|
| 2018 |
Chen X, Zhang J, Kim B, Jaitpal S, Meng SS, Adjepong K, Imamura S, Wake H, Nishibori M, Stopa EG, Stonestreet BS. High-mobility group box-1 translocation and release after hypoxic ischemic brain injury in neonatal rats. Experimental Neurology. PMID 30217406 DOI: 10.1016/J.Expneurol.2018.09.007 |
0.303 |
|
| 2018 |
Ott BR, Jones RN, Daiello LA, de la Monte SM, Stopa EG, Johanson CE, Denby C, Grammas P. Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines. Frontiers in Aging Neuroscience. 10: 245. PMID 30186149 DOI: 10.3389/Fnagi.2018.00245 |
0.32 |
|
| 2018 |
Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, et al. Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis. Fluids and Barriers of the Cns. 15: 18. PMID 29848382 DOI: 10.1186/S12987-018-0102-9 |
0.356 |
|
| 2018 |
Klakotskaia D, Agca C, Richardson RA, Stopa EG, Schachtman TR, Agca Y. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. Plos One. 13: e0195469. PMID 29641600 DOI: 10.1371/Journal.Pone.0195469 |
0.344 |
|
| 2018 |
Steeland S, Gorlé N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, Van Imschoot G, Van Wonterghem E, De Rycke R, Kremer A, Lippens S, Stopa E, Johanson CE, Libert C, Vandenbroucke RE. Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease. Embo Molecular Medicine. 10. PMID 29472246 DOI: 10.15252/Emmm.201708300 |
0.372 |
|
| 2018 |
Johansona CE, Stopa EG, Daiello L, Monte Sdl, Keane M, Ott BR. Disrupted Blood-CSF Barrier to Urea and Creatinine in Mild Cognitive Impairment and Alzheimer's Disease Journal of Alzheimers Disease & Parkinsonism. 8: 1-7. DOI: 10.4172/2161-0460.1000435 |
0.338 |
|
| 2016 |
Zhang J, Klufas D, Manalo K, Adjepong K, Davidson JO, Wassink G, Bennet L, Gunn AJ, Stopa EG, Liu K, Nishibori M, Stonestreet BS. HMGB1 Translocation After Ischemia in the Ovine Fetal Brain. Journal of Neuropathology and Experimental Neurology. PMID 27151753 DOI: 10.1093/Jnen/Nlw030 |
0.334 |
|
| 2016 |
Chen X, Rivard L, Naqvi S, Nakada S, Padbury JF, Sanchez-Esteban J, Stopa EG, Lim YP, Stonestreet BS. Expression and localization of Inter-alpha Inhibitors in rodent brain. Neuroscience. PMID 26964679 DOI: 10.1016/J.Neuroscience.2016.03.009 |
0.356 |
|
| 2016 |
Daiello LA, Stopa EG, Ott BR, Monte Sdl, Johanson CE. Cns Molecular Gradients In Mild Cognitive Impairment And Alzheimer’S Disease: Implications For Blood-Brain Barrier Permeability Alzheimers & Dementia. 12: 1149. DOI: 10.1016/J.Jalz.2016.07.045 |
0.307 |
|
| 2015 |
Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg GD. P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations. Neurobiology of Aging. 36: 2475-82. PMID 26159621 DOI: 10.1016/J.Neurobiolaging.2015.05.020 |
0.383 |
|
| 2015 |
Silverberg GD, Miller MC, Pascale CL, Caralopoulos IN, Agca Y, Agca C, Stopa EG. Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP. Fluids and Barriers of the Cns. 12: 2. PMID 25685319 DOI: 10.1186/2045-8118-12-2 |
0.389 |
|
| 2015 |
Stopa EG, Padbury J, Daiello LA, Ott BR, Sharma S. P1-087: Placental tau, α-synuclein, Aβ, and app levels in preeclampsia: An Alzheimer's disease risk factor Alzheimer's & Dementia. 11: P372-P372. DOI: 10.1016/J.Jalz.2015.06.284 |
0.322 |
|
| 2014 |
Izzo NJ, Staniszewski A, To L, Fa M, Teich AF, Saeed F, Wostein H, Walko T, Vaswani A, Wardius M, Syed Z, Ravenscroft J, Mozzoni K, Silky C, Rehak C, ... ... Stopa E, et al. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. Plos One. 9: e111898. PMID 25390368 DOI: 10.1371/Journal.Pone.0111898 |
0.349 |
|
| 2014 |
Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids and Barriers of the Cns. 11: 10. PMID 24817998 DOI: 10.1186/2045-8118-11-10 |
0.326 |
|
| 2013 |
Hu K, Harper DG, Shea SA, Stopa EG, Scheer FA. Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia. Scientific Reports. 3: 2229. PMID 23863985 DOI: 10.1038/Srep02229 |
0.351 |
|
| 2012 |
Miller MC, Lambert-Messerlian GM, Eklund EE, Heath NL, Donahue JE, Stopa EG. Expression of inhibin/activin proteins and receptors in the human hypothalamus and basal forebrain. Journal of Neuroendocrinology. 24: 962-72. PMID 22296042 DOI: 10.1111/J.1365-2826.2012.02289.X |
0.316 |
|
| 2011 |
Rauch SM, Huen K, Miller MC, Chaudry H, Lau M, Sanes JR, Johanson CE, Stopa EG, Burgess RW. Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice. Journal of Neuropathology and Experimental Neurology. 70: 1124-37. PMID 22082664 DOI: 10.1097/Nen.0B013E31823B0B12 |
0.391 |
|
| 2011 |
Podvin S, Gonzalez AM, Miller MC, Dang X, Botfield H, Donahue JE, Kurabi A, Boissaud-Cooke M, Rossi R, Leadbeater WE, Johanson CE, Coimbra R, Stopa EG, Eliceiri BP, Baird A. Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury. Plos One. 6: e24609. PMID 21935431 DOI: 10.1371/Journal.Pone.0024609 |
0.318 |
|
| 2011 |
Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, Leadbeater WE, Roberton A, Dang X, Knowling SE, Cardenas-Galindo E, Donahue JE, Stopa EG, Johanson CE, Coimbra R, Eliceiri BP, et al. Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury. Fluids and Barriers of the Cns. 8: 6. PMID 21349154 DOI: 10.1186/2045-8118-8-6 |
0.329 |
|
| 2011 |
Johanson C, Stopa E, McMillan P, Roth D, Funk J, Krinke G. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicologic Pathology. 39: 186-212. PMID 21189316 DOI: 10.1177/0192623310394214 |
0.351 |
|
| 2011 |
Johanson C, Stopa E, Baird A, Sharma H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 115-33. PMID 20936524 DOI: 10.1007/S00702-010-0498-0 |
0.35 |
|
| 2011 |
Stopa E. Gene expression profiling of choroid plexus in Alzheimer's disease reveals important implications of CSF dynamics Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2047 |
0.368 |
|
| 2010 |
Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, Donahue JE, Johanson CE. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. Journal of Neuropathology and Experimental Neurology. 69: 1034-43. PMID 20838242 DOI: 10.1097/Nen.0B013E3181F46E25 |
0.328 |
|
| 2010 |
Gonzalez AM, Leadbeater W, Podvin S, Borboa A, Burg M, Sawada R, Rayner J, Sims K, Terasaki T, Johanson C, Stopa E, Eliceiri B, Baird A. Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid. Brain Research. 1359: 1-13. PMID 20732308 DOI: 10.1016/J.Brainres.2010.08.044 |
0.305 |
|
| 2010 |
Gonzalez AM, Taylor WM, Johanson CE, King JC, Leadbeater WE, Stopa EG, Baird A. Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain. Cerebrospinal Fluid Research. 7: 13. PMID 20707896 DOI: 10.1186/1743-8454-7-13 |
0.336 |
|
| 2010 |
Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD, Alzheimer's Disease Neuroimaging Initiative. Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: 647-57. PMID 20182051 DOI: 10.3233/Jad-2010-1406 |
0.378 |
|
| 2010 |
Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. Journal of Neuropathology and Experimental Neurology. 69: 98-108. PMID 20010299 DOI: 10.1097/Nen.0B013E3181C8Ad2F |
0.36 |
|
| 2010 |
Donahue JE, Miller MC, Breese V, Podvin S, Eliceiri B, Jackson CL, Johanson CE, Stopa EG, Gonzalez AM, Baird A. ECRG-4 expression in normal and neoplastic choroid plexus Cerebrospinal Fluid Research. 7. DOI: 10.1186/1743-8454-7-S1-S32 |
0.311 |
|
| 2009 |
Johanson C, Messier A, Miller M, Pascale C, Vasudevan K, Donahue J, Stopa E, Sabo E, Caralopoulos I, Klinge P, Brinker T, Silverberg G. Periventricular destabilization and ventriculomegaly in aging rats: implications for reduced neurogenesis and cognition Cerebrospinal Fluid Research. 6. DOI: 10.1186/1743-8454-6-S2-S16 |
0.346 |
|
| 2009 |
Stopa E, Miller M, Blay E, McMillan P, Coffin D, Baird A, Donahue J, Johanson C. Altered ependyma and leptomeninges in transgenic mice that over express FGF2 and amyloid precursor protein: evidence for early hydrocephalus Cerebrospinal Fluid Research. 6. DOI: 10.1186/1743-8454-6-S1-S4 |
0.359 |
|
| 2009 |
Ott BR, Cohen RA, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD. P2-131: The relationship between brain ventricular volume and cerebrospinal fluid levels of A-beta and tau in apolipoprotein E4 positive normal controls and patients with Alzheimer's disease Alzheimer's & Dementia. 5: P299-P300. DOI: 10.1016/J.Jalz.2009.04.442 |
0.36 |
|
| 2008 |
Davis JD, Podolanczuk A, Donahue JE, Stopa E, Hennessey JV, Luo LG, Lim YP, Stern RA. Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients. Current Aging Science. 1: 175-81. PMID 20021390 DOI: 10.2174/1874609810801030175 |
0.347 |
|
| 2008 |
Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Research. 1230: 273-80. PMID 18657529 DOI: 10.1016/J.Brainres.2008.06.124 |
0.383 |
|
| 2008 |
Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Research. 5: 10. PMID 18479516 DOI: 10.1186/1743-8454-5-10 |
0.343 |
|
| 2008 |
Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain : a Journal of Neurology. 131: 1609-17. PMID 18372313 DOI: 10.1093/Brain/Awn049 |
0.329 |
|
| 2008 |
Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, Hovanesian V, Hulette CM, Vitek MP, Cohen RA. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype. Stroke; a Journal of Cerebral Circulation. 39: 814-21. PMID 18258839 DOI: 10.1161/Strokeaha.107.493429 |
0.347 |
|
| 2008 |
Wu C, Geula C, Stopa E, Mao Z, Wang X. P3-308: Early expression of the Fas-signaling adaptor protein FADD is linked with hyperphosphorylated Tau protein at the preclinical stage of Alzheimer's disease Alzheimer's & Dementia. 4: T612-T612. DOI: 10.1016/J.Jalz.2008.05.1877 |
0.311 |
|
| 2007 |
Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiology of Aging. 28: 977-86. PMID 16782234 DOI: 10.1016/J.Neurobiolaging.2006.05.016 |
0.376 |
|
| 2006 |
Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathologica. 112: 405-15. PMID 16865397 DOI: 10.1007/S00401-006-0115-3 |
0.387 |
|
| 2006 |
Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochirurgica. Supplement. 96: 451-6. PMID 16671503 DOI: 10.1007/3-211-30714-1_92 |
0.343 |
|
| 2006 |
Asayama K, Olson M, Kowall NW, Stopa EG, Harper DG. P2-087: Comprehensive evaluation of disruption of circadian rhythm of Alzheimer's disease: Interaction of polysomnography and physiology Alzheimer's & Dementia. 2: S258-S258. DOI: 10.1016/J.Jalz.2006.05.924 |
0.308 |
|
| 2005 |
Johanson CE, Duncan JA, Stopa EG, Baird A. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharmaceutical Research. 22: 1011-37. PMID 16028003 DOI: 10.1007/S11095-005-6039-0 |
0.371 |
|
| 2005 |
Johanson C, Flaherty S, Duncan J, Stopa E, Silverberg G. Aging rat brain: a model for analyzing interactions among CSF dynamics, ventriculomegaly and the β-amyloid retention of alzheimer's disease Cerebrospinal Fluid Research. 2: 1-1. DOI: 10.1186/1743-8454-2-S1-S6 |
0.396 |
|
| 2004 |
Johanson C, McMillan P, Tavares R, Spangenberger A, Duncan J, Silverberg G, Stopa E. Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease. Cerebrospinal Fluid Research. 1: 3. PMID 15679944 DOI: 10.1186/1743-8454-1-3 |
0.42 |
|
| 2004 |
Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiology of Aging. 25: 771-81. PMID 15165702 DOI: 10.1016/J.Neurobiolaging.2003.04.009 |
0.324 |
|
| 2004 |
Chang HT, Cortez S, Vonsattel JP, Stopa EG, Schelper RL. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin. Acta Neuropathologica. 108: 10-6. PMID 15108011 DOI: 10.1007/S00401-004-0836-0 |
0.363 |
|
| 2004 |
Johanson C, McMillan P, Duncan J, Stopa E. Volume transmission of CSF: complications in aging and Alzheimer's disease Cerebrospinal Fluid Research. 1: 1-1. DOI: 10.1186/1743-8454-1-S1-S22 |
0.316 |
|
| 2004 |
Wu C, Stopa E, Geula C, Thal L. P3-250 Neurofibrillary degeneration is linked with an apoptotic signal - fas-associated death domain in the basal forebrain cholinergic neurons of Alzheimer's disease Neurobiology of Aging. 25: S425-S426. DOI: 10.1016/S0197-4580(04)81400-3 |
0.314 |
|
| 2004 |
Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, Hovanesian V, Donahue JE, Hullette CM, Vitek MP, Stopa EG. P3-183 Microvascular damage in Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81335-6 |
0.313 |
|
| 2004 |
Donahue JE, Johanson CE, Duncan JA, Silverberg GD, Tavares R, Hovanesian V, Stopa EG. O1-01-04 Rage, LRP-1, and vascular amyloid in Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80031-9 |
0.306 |
|
| 2003 |
Lahousse SA, Stopa EG, Mulberg AE, de la Monte SM. Reduced expression of the cystic fibrosis transmembrane conductance regulator gene in the hypothalamus of patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 5: 455-62. PMID 14757935 DOI: 10.3233/Jad-2003-5605 |
0.36 |
|
| 2003 |
Anthony SG, Schipper HM, Tavares R, Hovanesian V, Cortez SC, Stopa EG, Johanson CE. Stress protein expression in the Alzheimer-diseased choroid plexus. Journal of Alzheimer's Disease : Jad. 5: 171-7. PMID 12897402 DOI: 10.3233/Jad-2003-5301 |
0.333 |
|
| 2003 |
Weaver CE, McMillan PN, Duncan JA, Stopa EG, Johanson CE. Hydrocephalus disorders: their biophysical and neuroendocrine impact on the choroid plexus epithelium Advances in Molecular and Cell Biology. 31: 269-293. DOI: 10.1016/S1569-2558(03)31012-4 |
0.341 |
|
| 2002 |
Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S, Hovanesian V, Fallon J, Kuo-Leblanc V, Glass D, Hulette C, Rosenberg C, Vitek M, Stopa E. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. Journal of the Neurological Sciences. 203: 183-7. PMID 12417381 DOI: 10.1016/S0022-510X(02)00288-5 |
0.348 |
|
| 2002 |
Luo L, Yano N, Mao Q, Jackson IM, Stopa EG. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. Journal of Alzheimer's Disease : Jad. 4: 97-103. PMID 12214133 DOI: 10.3233/Jad-2002-4204 |
0.361 |
|
| 2002 |
Ma Y, Chai L, Cortez SC, Stopa EG, Steinhoff MM, Ford D, Morgan J, Maizel AL. SALL1 expression in the human pituitary-adrenal/gonadal axis. The Journal of Endocrinology. 173: 437-48. PMID 12065233 DOI: 10.1677/Joe.0.1730437 |
0.303 |
|
| 2001 |
Adamec E, Chang HT, Stopa EG, Hedreen JC, Vonsattel JP. Tau protein expression in frontotemporal dementias. Neuroscience Letters. 315: 21-4. PMID 11711205 DOI: 10.1016/S0304-3940(01)02314-X |
0.356 |
|
| 2001 |
Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, Volicer L. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Archives of General Psychiatry. 58: 353-60. PMID 11296096 DOI: 10.1001/Archpsyc.58.4.353 |
0.331 |
|
| 2001 |
Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, Baird A, Johanson CE. Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease? Experimental Neurology. 167: 40-7. PMID 11161591 DOI: 10.1006/Exnr.2000.7545 |
0.359 |
|
| 2001 |
Chorsky RL, Yaghmai F, Hill WD, Stopa EG. Alzheimer's disease: a review concerning immune response and microischemia. Medical Hypotheses. 56: 124-7. PMID 11133269 DOI: 10.1054/Mehy.2000.1148 |
0.36 |
|
| 2000 |
Mihály E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. The Journal of Clinical Endocrinology and Metabolism. 85: 2596-603. PMID 10902813 DOI: 10.1210/Jcem.85.7.6662 |
0.331 |
|
| 2000 |
Berzin TM, Zipser BD, Rafii MS, Kuo-Leblanc V, Yancopoulos GD, Glass DJ, Fallon JR, Stopa EG. Agrin and microvascular damage in Alzheimer's disease. Neurobiology of Aging. 21: 349-55. PMID 10867220 DOI: 10.1016/S0197-4580(00)00121-4 |
0.418 |
|
| 1999 |
Johanson CE, Szmydynger-Chodobska J, Chodobski A, Baird A, McMillan P, Stopa EG. Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus. The American Journal of Physiology. 277: R263-71. PMID 10409281 DOI: 10.1152/Ajpregu.1999.277.1.R263 |
0.325 |
|
| 1999 |
Donahue JE, Berzin TM, Rafii MS, Glass DJ, Yancopoulos GD, Fallon JR, Stopa EG. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proceedings of the National Academy of Sciences of the United States of America. 96: 6468-72. PMID 10339611 DOI: 10.1073/Pnas.96.11.6468 |
0.424 |
|
| 1999 |
Kim KH, Patel L, Tobet SA, King JC, Rubin BS, Stopa EG. Gonadotropin-releasing hormone immunoreactivity in the adult and fetal human olfactory system. Brain Research. 826: 220-9. PMID 10224299 DOI: 10.1016/S0006-8993(99)01271-8 |
0.313 |
|
| 1999 |
Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, Satlin A. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. Journal of Neuropathology and Experimental Neurology. 58: 29-39. PMID 10068311 DOI: 10.1097/00005072-199901000-00004 |
0.407 |
|
| 1998 |
Guglielmo MA, Chan PT, Cortez S, Stopa EG, McMillan P, Johanson CE, Epstein M, Doberstein CE. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: the potential role of apoptosis. Neurological Research. 20: 283-96. PMID 9618690 DOI: 10.1080/01616412.1998.11740520 |
0.3 |
|
| 1998 |
Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain. Synapse (New York, N.Y.). 29: 116-27. PMID 9593102 DOI: 10.1002/(Sici)1098-2396(199806)29:2<116::Aid-Syn3>3.0.Co;2-A |
0.319 |
|
| 1998 |
Brecher K, Stopa EG, Kenney K. Concurrent herpes simplex virus encephalitis and Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry. 64: 418-9. PMID 9527177 DOI: 10.1136/Jnnp.64.3.418A |
0.311 |
|
| 1998 |
Fenton H, Finch PW, Rubin JS, Rosenberg JM, Taylor WG, Kuo-Leblanc V, Rodriguez-Wolf M, Baird A, Schipper HM, Stopa EG. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Research. 779: 262-70. PMID 9473690 DOI: 10.1016/S0006-8993(97)00958-X |
0.408 |
|
| 1996 |
Baird A, Kuo-LeBlanc V, Rodriguez-Wolf M, Natarajan R, Song PC, Vitek M, Kohls M, Gonzalez AM, Stopa EG. 731 Regional variations in basic fibroblast growth factor (FGF-2), β-amyloid, synaptophysin and GFAP in Alzheimer's Disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80733-0 |
0.307 |
|
| 1996 |
Stopa E, Vitek M, Rubin B, Schmechel D, Kuo-Leblanc. V, Wei Y, Song P, King J, Boteva K, Mitsuda N, Gilbert J, Roses A. 67 In-situ localization of S182 mRNA in sporadic Alzheimer's disease (AD) Neurobiology of Aging. 17: S17. DOI: 10.1016/S0197-4580(96)80069-8 |
0.323 |
|
| 1995 |
Satlin A, Volicer L, Stopa EG, Harper D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiology of Aging. 16: 765-71. PMID 8532109 DOI: 10.1016/0197-4580(95)00059-N |
0.308 |
|
| 1995 |
Schipper HM, Cissé S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Annals of Neurology. 37: 758-68. PMID 7778849 DOI: 10.1002/Ana.410370609 |
0.383 |
|
| 1994 |
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 91: 4766-70. PMID 8197133 DOI: 10.1073/Pnas.91.11.4766 |
0.309 |
|
| 1991 |
Stopa EG, Koh ET, Svendsen CN, Rogers WT, Schwaber JS, King JC. Computer-assisted mapping of immunoreactive mammalian gonadotropin-releasing hormone in adult human basal forebrain and amygdala. Endocrinology. 128: 3199-207. PMID 2036986 DOI: 10.1210/Endo-128-6-3199 |
0.316 |
|
| 1991 |
Friedman DI, Johnson JK, Chorsky RL, Stopa EG. Labeling of human retinohypothalamic tract with the carbocyanine dye, DiI. Brain Research. 560: 297-302. PMID 1760734 DOI: 10.1016/0006-8993(91)91246-W |
0.3 |
|
| 1990 |
Stopa EG, Gonzalez AM, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A. Basic fibroblast growth factor in Alzheimer's disease. Biochemical and Biophysical Research Communications. 171: 690-6. PMID 2403357 DOI: 10.1016/0006-291X(90)91201-3 |
0.405 |
|
| 1984 |
Stopa EG, King JC, Lydic R, Schoene WC. Human brain contains vasopressin and vasoactive intestinal polypeptide neuronal subpopulations in the suprachiasmatic region. Brain Research. 297: 159-63. PMID 6372941 DOI: 10.1016/0006-8993(84)90553-5 |
0.334 |
|
| Show low-probability matches. |
